ACCESS Newswire

Curve Energy Corp. And Lot 49 Capital Corp. Sign Definitive Agreement for Amalgamation and TSX Venture Listing

Share

VANCOUVER, BC / ACCESS Newswire / March 11, 2025 / Curve Energy Corp. (the "Company" or "Curve") and Lot 49 Capital Corp. ("Lot 49") are pleased to announce that they have entered into a definitive agreement (the "Definitive Agreement") to combine the two companies (the "Transaction") which will constitute a reverse takeover transaction ("RTO") of Lot 49. The Transaction is structured to facilitate the listing of the combined entity on the TSX Venture Exchange ("TSXV").

The Transaction is expected to be completed by way of a three-cornered amalgamation under the provisions of the Business Corporations Act (British Columbia) whereby a wholly-owned subsidiary of Lot 49 ("SubCo"), will amalgamate with Curve. All of the issued and outstanding common shares of SubCo and Curve following the amalgamation will be immediately exchanged for common shares of Lot 49 ("Lot 49 Shares") on a one-for-one basis.

In connection with closing of the Transaction, Lot 49 intends to settle approximately $138,722 of outstanding debt through the issuance of Lot 49 Shares and complete a subscription receipt financing for gross proceeds of approximately $250,000, with such subscription receipts convertible into Lot 49 Shares on closing of the Transaction. After giving effect to the proposed debt settlement and subscription receipt financing, it is anticipated that approximately 2,954,478 Lot 49 Shares will be outstanding immediately prior to closing of the Transaction. In addition, Curve intends to close a non-brokered private placement for gross proceeds of up to $750,000 prior to closing of the Transaction, such that upon completion of the Transaction, it is anticipated that approximately 124,982,673 Lot 49 Shares will be issued to Curve shareholders, giving Curve shareholders ownership of approximately 97.7% of the resulting issuer.

As part of the Transaction, the current board and management team of Lot 49 will be replaced by Curve's existing leadership, ensuring continuity in Curve's strategic vision and operational execution.

"We are excited to take this next step with Lot 49, positioning Curve Energy for growth and innovation in the fuel and refinery technology sector," said Peter Joyce, CEO of Curve. "Our focus remains on advancing proprietary green chemistry solutions that transform the maritime fuel industry while enhancing sustainability across broader fuel markets."

The completion of the Transaction is subject to satisfaction or waiver of customary closing conditions and receipt of certain necessary regulatory approvals, including acceptance by the TSXV. Further details, including timelines and any required shareholder approvals, will be provided as the Transaction progresses.

About Curve Energy Corp.

Curve Energy Corp. is a technology-driven company pioneering advanced green chemistry solutions for the maritime fuel industry and broader energy markets. The company's patented desulfurization technology upgrades Heavy Fuel Oil (HSFO) by removing sulfur, nitrogen, and vanadium, converting it into Very Low Sulfur Fuel Oil (VLSFO) under near-ambient conditions. Curve's technology eliminates the need for carbon-intensive SMR hydrogen desulfurization, blended fuels, and scrubbers, which operate by spraying exhaust gases with seawater, causing a reaction with sulfur oxides that forms sulfuric acid, which is then discharged into the ocean.

Curve's flagship product, Benchmark VLSFO Curve - SR™ (Curve's Straight Run), is engineered to meet both current and anticipated regulatory standards. As global emissions and fuel quality requirements become increasingly stringent, Curve's scalable and environmentally responsible solution offers an industry-leading yield rate, delivering a high-efficiency, low-carbon alternative for maritime and industrial fuel applications. Additionally, Curve's process enhances profitability by enabling the use of discounted feedstocks that alternative solutions cannot efficiently process, unlocking new economic advantages for refiners and fuel suppliers.

The Company's proprietary process produces IMO 2020-compliant VLSFO and operates within a closed-loop system, maximizing yield efficiency while minimizing environmental impact. Curve's Tank-to-Tank System allows seamless scalability and deployment at ports, terminals, and refineries, requiring minimal infrastructure modifications.

Curve is strategically focused on growth and innovation in refining, industrial fuels, and petrochemicals, with near-term objectives including the development of its first commercial-scale plant. Additionally, the Company is advancing digital refinery optimization, leveraging data-driven solutions to enhance operational efficiency and sustainability.

Looking ahead, Curve is positioned to expand into emerging fuel markets, including alternative fuel development, carbon reduction technologies, and advanced refining solutions. As global energy demand evolves, the Company continues to explore new applications, strategic partnerships, and infrastructure deployment opportunities to accelerate sustainable growth and long-term value creation.

For more information about Curve, visit https://www.curvenrg.com

On behalf of the Board of Directors

Peter Joyce
Chief Executive Officer

Forward Looking Information

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions with respect to, among other things: the business plans of Curve and the resulting issuer, the pro forma capital structure of the resulting issuer, the Transaction (including TSXV approval and the closing of the Transaction); completion of the anticipated debt settlement and financings; the efficiency and anticipated applications of the Company's product offerings; and management's beliefs regarding the Company's ability to expand into emerging fuel markets.

These forward‐looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These risks and uncertainties include, among other things, the risks that: the Company and the resulting issuer will not be able to achieve its business plans; the anticipated pro forma capital structure of the resulting issuer will differ from what is contemplated; the parties may be unable to close the debt settlement and financings; the Company and Lot 49 will be unable to close the Transaction or obtain the requisite third party approvals to close the Transaction; and new laws or regulations could adversely affect the resulting issuer's business and results of operations.

In making the forward looking statements in this news release, the Company has applied several material assumptions, including without limitation, that: the Company and the resulting issuer will be able to carry out its combined business plans as anticipated; the parties will be able to close the debt settlement and financings and will be able to do so on anticipated timelines; and the Company and Lot 49 will receive all necessary third party approvals and will close the Transaction.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.

CONTACT:

Peter Joyce
info@curvenrg.com

SOURCE: Curve Energy



View the original press release on ACCESS Newswire

Curve Energy

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release

OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper

Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release

VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc

GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release

MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o

GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 202617.11.2025 03:05:00 CET | Press release

Two Aerospace Leaders Are Bringing Airborne Early Warning and Control to UAS DUBAI, UAE / ACCESS Newswire / November 16, 2025 / Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. The demo will be conducted at GA-ASI's Desert Horizon flight operations facility in Southern California using a GA-ASI MQ-9B equipped with AEW&C supplied by Saab. In partnership with Saab, a leading company in AEW&C systems, GA-ASI is pairing Saab's AEW sensors with the world's longest-range, highest-endurance RPA, the MQ-9B. At sea or over land, adding AEW capabilities on MQ-9B enables persistent air surveillance and enables AEW in areas of the world where it doesn't currently exist or is unaffordable, such as for navy aircraft carriers at sea. "Adding AEW&C to the MQ-9B bring

Doha Tattoo Festival Announced as Ticket Sales Officially Open16.11.2025 12:45:00 CET | Press release

DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village. A press conference held at Katara Cultural Village unveiled the line-up of participating bands and ticket details, attended by members of the Doha Tattoo organising committee and partner representatives. The Doha Tattoo will combine precision with musical artistry, showcasing performances by distinguished musical bands from seven countries: the United Kingdom, the United States of America, Turkia, Hashemite Kingdom of Jordan , the Sultanate of Oman, Kazakhstan, and the State of Qatar. The participating line-up includes the Irish Guards and the Royal Air Force Music Services from the United Kingdom, the United States Air Force

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye